Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.
Clinical trial NCT04731298 · TERMINATED
Trial details
- NCT number
- NCT04731298
- Sponsor
- Swedish Orphan Biovitrum
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2022-04-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.